[go: up one dir, main page]

WO1998003540A3 - 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations - Google Patents

1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations Download PDF

Info

Publication number
WO1998003540A3
WO1998003540A3 PCT/EP1997/003774 EP9703774W WO9803540A3 WO 1998003540 A3 WO1998003540 A3 WO 1998003540A3 EP 9703774 W EP9703774 W EP 9703774W WO 9803540 A3 WO9803540 A3 WO 9803540A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
pharmaceutical formulations
substituted cycloalkane
cycloalkane derivatives
thrombine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1997/003774
Other languages
French (fr)
Other versions
WO1998003540A2 (en
Inventor
Bugno Cristina Di
Raffaello Giorgi
Nicholas Harmat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Menarini Industrie Farmaceutiche Riunite SRL
Original Assignee
A Menarini Industrie Farmaceutiche Riunite SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Menarini Industrie Farmaceutiche Riunite SRL filed Critical A Menarini Industrie Farmaceutiche Riunite SRL
Priority to AU35437/97A priority Critical patent/AU3543797A/en
Publication of WO1998003540A2 publication Critical patent/WO1998003540A2/en
Publication of WO1998003540A3 publication Critical patent/WO1998003540A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/10—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compounds containing a 1,2-disubstituted cycloalkane or cycloalkene ring with inhibitory activity on serinoproteases of general formula (I) wherein A is selected from the (CH2)n group with n = -3, CH=CH and Ar, L, X, Q, Y, W are as defined; processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof as therapeutical agents.
PCT/EP1997/003774 1996-07-19 1997-07-15 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations Ceased WO1998003540A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU35437/97A AU3543797A (en) 1996-07-19 1997-07-15 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI96A001512 1996-07-19
IT96MI001512A IT1283467B1 (en) 1996-07-19 1996-07-19 DERIVATIVES OF 1,2 SUBSTITUTED CYCLOALKANES AS THROMBIN INHIBITORS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE IN FORMULATIONS

Publications (2)

Publication Number Publication Date
WO1998003540A2 WO1998003540A2 (en) 1998-01-29
WO1998003540A3 true WO1998003540A3 (en) 1998-04-09

Family

ID=11374623

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/003774 Ceased WO1998003540A2 (en) 1996-07-19 1997-07-15 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations

Country Status (3)

Country Link
AU (1) AU3543797A (en)
IT (1) IT1283467B1 (en)
WO (1) WO1998003540A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1066247T3 (en) * 1998-03-31 2007-04-02 Vertex Pharma Inhibitors of serine proteases, especially hepatitis C virus NS3 protease
US6462076B2 (en) * 2000-06-14 2002-10-08 Hoffmann-La Roche Inc. Beta-amino acid nitrile derivatives as cathepsin K inhibitors
RU2004120784A (en) 2001-12-04 2005-08-10 Ф.Хоффманн-Ля Рош Аг (Ch) SUBSTITUTED 2-AMINOCYCLOCALANOCARBOXAMIDES AND THEIR APPLICATION AS Cysteine Protease Inhibitors
US6759428B2 (en) 2001-12-04 2004-07-06 Roche Palo Alto Llc Indole nitriles
WO2005000793A1 (en) * 2003-06-26 2005-01-06 Taisho Pharmaceutical Co., Ltd. 2-substituted cycloalkylcarboxylic acid derivative
CN105026407B (en) * 2012-12-07 2017-09-08 维纳拓尔斯制药公司 β-lactamase inhibitors
CN114437119B (en) * 2020-10-30 2024-08-09 苏州开拓药业股份有限公司 C-Myc protein inhibitor and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478745A (en) * 1981-01-13 1984-10-23 Richter Gedeon Vegyeszeti Gyar R.T. T-Butyloxy-carbonyl-D-phenylalanyl-L-prolyl-L-arginine aldehyde hemisulfate, D-phenylalanyl-L-prolyl-L-arginine aldehyde sulfate and process for the preparation thereof
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478745A (en) * 1981-01-13 1984-10-23 Richter Gedeon Vegyeszeti Gyar R.T. T-Butyloxy-carbonyl-D-phenylalanyl-L-prolyl-L-arginine aldehyde hemisulfate, D-phenylalanyl-L-prolyl-L-arginine aldehyde sulfate and process for the preparation thereof
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides

Also Published As

Publication number Publication date
ITMI961512A1 (en) 1998-01-19
WO1998003540A2 (en) 1998-01-29
ITMI961512A0 (en) 1996-07-19
AU3543797A (en) 1998-02-10
IT1283467B1 (en) 1998-04-21

Similar Documents

Publication Publication Date Title
ATE13740T1 (en) PEPTIDESTERS, PROCESSES FOR THE MANUFACTURE OF SAME AND PHARMACEUTICALS OR DIAGNOSTICS CONTAINING THEM.
ATE246190T1 (en) HETEROCYCLIC COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE IN THE TREATMENT OF DIABETIS AND RELATED DISEASES
MX9604020A (en) Arylalkyldiazinones.
IL99759A (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
CA2186511A1 (en) Pyrimidinyl derivatives as interleukin inhibitors
DE69030206D1 (en) Pyrazolopyridine compounds and process for their preparation
DE69130412D1 (en) Pyrazolopyridine compound and process for its preparation
CA2143636A1 (en) Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
IL112622A0 (en) Camptothecin derivatives, their preparation and pharmaceutical compositions containing them
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
CA2179733A1 (en) Anticonvulsant pseudofructopyranose sulfamates
WO1998003540A3 (en) 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations
RU94046270A (en) Lactam dipeptides showing inhibiting activity with respect to human leukocyte elastase, method of synthesis, pharmaceutical composition
AU7270798A (en) Antithrombotic agents
AU7592796A (en) Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
TW252979B (en)
CA2007261A1 (en) Novel tetralin derivatives
MX9806229A (en) BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5'alpha'-REDUCTASES INHIBITORS.
WO1999005103A3 (en) 2o(s)-7-ethyl-9-(n-methyl-n-phenyl)amidino-camptothecin, its preparation and its use as antitumor agent
AU7470098A (en) Antithrombotic agents
EP0333000A3 (en) Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
CA2178085A1 (en) Glutaramide derivatives
EP0924204A4 (en) 2-PHENYLMORPHOLIN-5-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 98505616

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase